Hindustan Bio Sciences News

Hindustan Bio Sciences Reports Share Acquisition

Bosco Armando Menezes & Emily Bosco Menezes acquire 15,000 shares through open market purchase, increasing combined holding to 5.12% in Hindustan Bio Sciences Limited.

Hindustan Biosciences Reports Mixed Quarterly Performance with Revenue Decline

Hindustan Biosciences Limited reported a loss of Rs 5.85 lakhs for the quarter ended September 30, 2025, compared to a profit of Rs 1.40 lakhs in the previous quarter. Revenue from operations dropped to Rs 32.19 lakhs from Rs 42.54 lakhs in the comparable period. For the half-year period, the company posted a loss of Rs 4.45 lakhs. Total expenses decreased to Rs 6.71 lakhs from Rs 32.41 lakhs in the previous quarter. The company's cash and cash equivalents stood at Rs 1.63 lakhs. Employee benefit expenses were Rs 4.96 lakhs for the quarter. The Board of Directors approved these unaudited standalone financial results in their meeting held on October 31, 2025.

Hindustan Bio Sciences Reports Quarterly Financial Results for June 2025

Hindustan Bio Sciences Ltd published its unaudited financial results for the quarter ended June 30, 2025, in compliance with regulatory requirements. The company reported total income of ₹32.19 lakhs compared to ₹41.11 lakhs in the same quarter last year. Net profit after tax stood at ₹1.40 lakhs versus ₹8.18 lakhs in the previous year quarter. The company operates in the pharmaceutical trading segment. Results were reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 31, 2025, with statutory auditors expressing an unmodified audit opinion.

Hindustan Biosciences Reports Q1 Results, Appoints New Company Secretary

Hindustan Biosciences Ltd. reported quarterly results showing revenue from operations of Rs 32.19 lakhs and profit of Rs 1.40 lakhs for the quarter ended June 30, 2025. The company announced the resignation of Company Secretary Devanshu Ravinder Dange due to personal reasons, effective July 31, 2025. Shailendra Vyas has been appointed as the new Company Secretary, Key Managerial Personnel and Compliance Officer from August 1, 2025. The board approved the notice for the 33rd Annual General Meeting scheduled for September and adopted the Secretarial Audit Report. VBSS Prasad was appointed as scrutinizer for e-voting at the upcoming AGM.